Stifel Financial
ADMA icon

Stifel Financial’s ADMA Biologics ADMA Stock Holding History

Stifel Financial’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-26,931
Closed -$243K – 3705
2026
Q1 		$243K Sell
26,931
-2,988
-10% -$47.2K ﹤0.01% 3312
2025
Q4 		$546K Sell
29,919
-45,748
-60% -$771K ﹤0.01% 2808
2025
Q3 		$1.11M Buy
75,667
+15,605
+26% +$267K ﹤0.01% 2337
2025
Q2 		$1.09M Buy
+60,062
New +$1.22M ﹤0.01% 2274

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Stifel Financial's ADMA Position: Q2 2026 in Review

Stifel Financial sold out of ADMA Biologics (ADMA) in Q2 2026, closing a stake of 26,931 shares — an estimated $243K sold.

Stifel Financial first reported a position in ADMA in Q2 2025 and held it in 4 quarters. The position peaked at $1.11M in Q3 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Stifel Financial reported no remaining ADMA Biologics position as of Q2 2026 after selling out during the quarter.
  • Stifel Financial sold 26,931 ADMA Biologics shares in Q2 2026, an estimated $243K.
  • Stifel Financial first reported a position in ADMA Biologics in Q2 2025 and held it in 4 quarters.
  • Stifel Financial's ADMA Biologics position peaked at $1.11M in Q3 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.